cost utility analyses in diabetes a systematic review - First we reviewed costutility analyses CUAs atkins and diabetes related to diabetes published through the end of 2012 using the Tufts Medical Center CostEffectiveness Analysis Registry wwwcearegistryorg It is well documented that diabetes places a substantial economic burden on patients and the health care system 1 2 3In the United States costs associated with prediabetes and diabetes have increased from 174 billion in 2007 to 245 billion in 2012 including 176 billion direct medical costs and 69 billion indirect costs due to related disability and lost productivity 1 A Systematic Review Of CostUtility Analyses In Diabetes Costutility analyses in diabetes A systematic review and potential gains from using economic evidence Y Zhong 1 PJ Lin 1 JT Cohen 1 A Winn 2 PJ Neumann 1 1 Tufts Medical Center Boston MA USA We conducted a systematic review of costutility analyses CUAs related to diabetes published through 2012 using the Zhong Y Lin PJ Cohen JT Winn AN Neumann PJ Costutility analyses in diabetes a systematic review and implications from realworld evidence Value Health 2015182 308314 Engelgau MM Narayan KV Effectiveness of selfmanagement training in type 2 diabetes a systematic review of randomized controlled trials Diabetes Care Comprehensive costeffectiveness of diabetes management for the PLOS Odnoletkova I Costeffectiveness of therapeutic education to prevent the development and progression of type 2 diabetes systematic review J Diabetes Metab 201459 23 Evers S Goossens M de Vet H van Tulder M Ament A Criteria list for assessment of methodological quality of economic evaluations Consensus on Health Economic Criteria Objectives To systematically review the costeffectiveness of diabetes interventions identify highvalue diabetes services and estimate potential gains from increasing their dd diabetes melitus utilization Methods The study consisted of two steps First we reviewed costutility analyses CUAs related to diabetes published through the end of 2012 using the Tufts Medical Center CostEffectiveness Analysis Costutility analyses in diabetes A systematic review and potential Costutility analyses in diabetes a systematic review and implications Most 70 diabetes CUAs focused on treatment rather than prevention Most used a health care payer perspective and were industrysponsored Of the 497 published costutility ratios 82 examined an intervention recommended by diabetes guidelines Approximately 73 of the interventions were costsaving or below 50000 per qualityadjusted life CostUtility Analyses in Diabetes A Systematic Review ResearchGate A systematic review and implications from realworld evidence Evaluating the CostUtility of Continuous Glucose Monitoring in Costeffectiveness of intensive interventions compared to standard care Costeffectiveness of intensive interventions compared to standard care in individuals with type 2 diabetes A systematic review and critical appraisal of decisionanalytic models Muhammad Usman a six conducted costutility analyses 22242530 and two conducted both costeffectiveness and costutility analyses The most To review and systematically synthesize the costeffectiveness of diabetes interventions Methods We conducted a systematic review of costutility analyses CUAs related to diabetes published between 1994 and 2012 using the Tufts Medical Center CostEffectiveness Analysis Registry wwwcearegistryorg Evaluating the CostUtility of Continuous Glucose Monitoring in Evaluating the CostUtility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data The review and its documentation adhered to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses PRISMA guidelines for CostUtility Analyses in Diabetes A diabetes type 2 supplements Systematic Review and Implications
esc 2019 guidelines diabetes
camilan sehat ibu hamil diabetes
